BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

A new clinical trial raises concerns about the safety of low doses of cannabidiol (CBD), even as CBD products continue to grow in popularity.

ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials Marseille, France, ...

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, ...

The agency says Juul's benefits as a less harmful alternative for adult smokers outweigh the risks of teen use. It's a major ...

The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...

Zero-sugar drinks are the fastest-growing products for Coca-Cola and PepsiCo. An industry analyst doubted there will be a full shift away from high-fructose corn syrup because of supply-chain issues.